EDESA BIOTECH, INC. Earnings Per Share (Basic)
EDESA BIOTECH, INC. (EDSA) reported Earnings Per Share (Basic) of -$0.60 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-08-13
- EDESA BIOTECH, INC. earnings per share, basic for the quarter ending 2026-06-30 was -$0.60.
- EDESA BIOTECH, INC. earnings per share, basic for the quarter ending 2026-03-31 was -$0.49.
- EDESA BIOTECH, INC. earnings per share, basic for the quarter ending 2025-12-31 was -$0.28.
- EDESA BIOTECH, INC. earnings per share, basic for the quarter ending 2025-09-30 was -$0.32.
- EDESA BIOTECH, INC. earnings per share, basic for fiscal 2025 was -$1.27.
- EDESA BIOTECH, INC. earnings per share, basic for fiscal 2024 was -$1.93.
- EDESA BIOTECH, INC. earnings per share, basic for fiscal 2023 was -$2.93.
- EDESA BIOTECH, INC. earnings per share, basic for fiscal 2016 was -$0.57.
| Period end | Earnings Per Share, Basic 1 month | Earnings Per Share, Basic 1 month as first filed | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 3 month as first filed | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 9 month as first filed | Earnings Per Share, Basic 12 month |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$0.60 10-Q · filed 2026-08-13 | -$1.10 derived: net income ÷ weighted average shares · filed 2026-08-13 | -$1.40 10-Q · filed 2026-08-13 | -$1.73 derived: net income ÷ weighted average shares · filed 2026-08-13 | ||||
| 2026-03-31 | -$0.49 10-Q · filed 2026-05-14 | -$0.78 10-Q · filed 2026-05-14 | -$1.11 derived: net income ÷ weighted average shares · filed 2026-05-14 | -$1.37 derived: net income ÷ weighted average shares · filed 2026-08-13 | ||||
| 2025-12-31 | -$0.28 10-Q · filed 2026-02-13 | -$0.60 derived: net income ÷ weighted average shares · filed 2026-02-13 | -$0.85 derived: net income ÷ weighted average shares · filed 2026-08-13 | -$1.14 derived: net income ÷ weighted average shares · filed 2026-08-13 | ||||
| 2025-09-30 | -$0.32 derived: net income ÷ weighted average shares · filed 2025-12-12 | -$0.57 derived: net income ÷ weighted average shares · filed 2026-08-13 | -$0.86 derived: net income ÷ weighted average shares · filed 2026-08-13 | -$1.27 10-K · filed 2025-12-12 | ||||
| 2025-06-30 | -$0.25 10-Q · filed 2026-08-13 | -$0.54 derived: net income ÷ weighted average shares · filed 2026-08-13 | -$0.95 10-Q · filed 2026-08-13 | -$1.25 derived: net income ÷ weighted average shares · filed 2026-08-13 | ||||
| 2025-03-31 | -$0.30 10-Q · filed 2026-05-14 | -$0.74 10-Q · filed 2026-05-14 | -$1.05 derived: net income ÷ weighted average shares · filed 2026-05-14 | -$1.54 derived: net income ÷ weighted average shares · filed 2026-05-14 | ||||
| 2024-12-31 | -$0.48 10-Q · filed 2026-02-13 | -$0.78 derived: net income ÷ weighted average shares · filed 2026-02-13 | -$1.30 derived: net income ÷ weighted average shares · filed 2026-02-13 | -$1.88 derived: net income ÷ weighted average shares · filed 2026-02-13 | ||||
| 2024-09-30 | -$0.30 derived: net income ÷ weighted average shares · filed 2025-12-12 | -$0.81 derived: net income ÷ weighted average shares · filed 2025-12-12 | -$1.39 derived: net income ÷ weighted average shares · filed 2025-12-12 | -$1.93 10-K · filed 2025-12-12 | ||||
| 2024-06-30 | -$0.52 10-Q · filed 2025-08-08 | -$1.10 derived: net income ÷ weighted average shares · filed 2025-08-08 | -$1.64 10-Q · filed 2025-08-08 | -$2.20 derived: net income ÷ weighted average shares · filed 2025-08-08 | ||||
| 2024-03-31 | -$0.58 10-Q · filed 2025-05-14 | -$1.12 10-Q · filed 2025-05-14 | -$1.69 derived: net income ÷ weighted average shares · filed 2025-05-14 | -$2.36 derived: net income ÷ weighted average shares · filed 2025-05-14 | ||||
| 2023-12-31 | -$0.54 10-Q · filed 2025-02-14 | -$1.10 derived: net income ÷ weighted average shares · filed 2025-02-14 | -$1.78 derived: net income ÷ weighted average shares · filed 2025-02-14 | |||||
| 2023-09-30 | -$0.57 derived: net income ÷ weighted average shares · filed 2024-12-13 | -$1.24 derived: net income ÷ weighted average shares · filed 2024-12-13 | -$2.93 10-K · filed 2024-12-13 | |||||
| 2023-06-30 | -$0.68 10-Q · filed 2024-08-09 | -$2.37 10-Q · filed 2024-08-09 | ||||||
| 2016-09-30 | -$0.13 derived: net income ÷ weighted average shares · filed 2017-12-01 | -$0.27 derived: net income ÷ weighted average shares · filed 2017-12-01 | -$0.57 10-K · filed 2016-12-14 | |||||
| 2016-06-30 | -$0.14 10-Q · filed 2016-08-09 | -$0.44 10-Q · filed 2016-08-09 | ||||||
| 2015-09-30 | -$0.19 derived: net income ÷ weighted average shares · filed 2017-12-01 | -$0.13 derived: net income ÷ weighted average shares · filed 2017-12-01 | -$0.05 derived: net income ÷ weighted average shares · filed 2017-12-01 | -$0.36 10-K · filed 2016-12-14 | ||||
| 2015-06-30 | $0.06 10-Q · filed 2016-08-09 | $0.01 10-Q · filed 2015-08-10 | $0.00 derived: net income ÷ weighted average shares · filed 2016-08-09 | -$0.16 10-Q · filed 2016-08-09 | -$0.02 10-Q · filed 2015-08-10 | |||
| 2015-03-31 | -$0.01 10-Q · filed 2015-05-11 | -$0.02 10-Q · filed 2015-05-11 | ||||||
| 2014-12-31 | -$0.02 10-Q · filed 2015-02-09 | |||||||
| 2014-09-30 | $0.14 10-K · filed 2016-12-14 | $0.01 10-Q · filed 2015-02-09 | ||||||
| 2014-08-31 | -$1.11 10-K · filed 2016-12-14 | |||||||
| 2014-06-30 | $0.04 10-Q · filed 2015-08-10 | $0.03 derived: net income ÷ weighted average shares · filed 2015-08-10 | -$0.05 10-Q · filed 2015-08-10 | |||||
| 2014-03-31 | -$0.02 10-Q · filed 2015-05-11 | -$0.09 10-Q · filed 2015-05-11 | ||||||
| 2013-12-31 | -$0.08 10-Q · filed 2015-02-09 | |||||||
| 2013-08-31 | -$2.81 10-K · filed 2015-12-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B |